Bacillus Coagulans

From Wikiwel
Share/Save/Bookmark
Jump to: navigation, search

Bacillus coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus, its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Bergey’s, it was finally transferred to the genus Bacillus.

Special Precautions of Bacillus Coagulans

  • There's some concern that use of probiotics may trigger a range of side effects, including digestive issues like gas and bloating.
  • Since probiotics may interact with medications used to suppress the immune system, it's crucial to talk to your doctor before using Bacillus coagulans in combination with any type of immunosuppresant drug.

Health Benefits and uses of Bacillus Coagulans are

Bacillus coagulans is a probiotic, which is a type of beneficial bacteria. Use of dietary supplements containing Bacillus coagulans is said to aid in the treatment of many health conditions, including several digestive disorders. Bacillus coagulans is used to treat the following health problems:

  • colitis
  • Crohn's disease
  • diarrhea
  • irritable bowel syndrome : Some research suggests that Bacillus coagulans may help treat certain symptoms of irritable bowel syndrome. A small study published in Postgraduate Medicine in 2009, for example, indicates that Bacillus coagulans may help abdominal pain and bloating related to irritable bowel syndrome. For the study, 44 patients took either Bacillus coagulans or a placebo every day for eight weeks. At the study's end, those treated with Bacillus coagulans showed a significantly greater improvement in pain and bloating (compared to those given the placebo). Additionally, a pilot study published in Methods and Findings in Experimental and Clinical Pharmacology in 2009 found that Bacillus coagulans may be helpful to irritable bowel syndrome patients suffering from diarrhea. In an eight-week-long experiment involving 52 diarrhea-predominant irritable bowel syndrome patients, researchers found that those given Bacillus coagulans experienced a significantly greater reduction in average number of bowel movements per day than those given a placebo.
  • to stimulate the immune system : Bacillus coagulans may help boost the immune system and stave off virus-induced respiratory tract infections (such as the common cold and the flu, according to a small study published in Postgraduate Medicine in 2009. The study involved 10 healthy men and women, each of whom was given Bacillus coagulans daily for 30 days. After their 30-day treatment with Bacillus coagulans, all of the study members were exposed to adenovirus (which causes respiratory illness) and influenza A (a strain of flu virus). Researchers found that use of Bacillus coagulans significantly increased the production of cells that play a key role in the body's immune response.
  • Some proponents claim that it can fight cancer as well.
  • In addition, it's thought that taking Bacillus coagulans while taking antibiotic medications may help protect against the side effects associated with antibiotic use (such as stomach troubles and yeast infections).

References

  • Baron M. "A patented strain of Bacillus coagulans increased immune response to viral challenge." Postgrad Med. 2009 Mar;121(2):114-8.
  • Dolin BJ. "Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome." Methods Find Exp Clin Pharmacol. 2009 Dec;31(10):655-9. doi: 10.1358/mf.2009.31.10.1441078.
  • Hun L. "Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS." Postgrad Med. 2009 Mar;121(2):119-24.